THALITONE Drug Patent Profile

✉ Email this page to a colleague

When do Thalitone patents expire, and what generic alternatives are available?

Thalitone is a drug marketed by Casper Pharma Llc and Monarch Pharms and is included in two NDAs.

The generic ingredient in THALITONE is chlorthalidone. There are twenty-one drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Thalitone

A generic version of THALITONE was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21^st, 1986.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for THALITONE?
What are the global sales for THALITONE?
What is Average Wholesale Price for THALITONE?

Summary for THALITONE

US Patents:	0
Applicants:	2
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	105
Clinical Trials:	4
Patent Applications:	4,053
Drug Prices:	Drug price information for THALITONE
What excipients (inactive ingredients) are in THALITONE?	THALITONE excipients list
DailyMed Link:	THALITONE at DailyMed

Drug patent expirations by year for THALITONE

Recent Clinical Trials for THALITONE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
North Carolina Translational and Clinical Sciences Institute	N/A
Anthony J Viera, MD, MPH	N/A
Virginia Commonwealth University	Phase 4

See all THALITONE clinical trials

Pharmacology for THALITONE

Drug Class	Thiazide-like Diuretic
Physiological Effect	Increased Diuresis

US Patents and Regulatory Information for THALITONE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988		RX	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-002	Feb 12, 1992	BX	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Monarch Pharms	THALITONE	chlorthalidone	TABLET;ORAL	088051-001	Nov 12, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for THALITONE

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for THALITONE

See the table below for patents covering THALITONE around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
European Patent Office	0125420	WATER SOLUBLE DISPERSIONS OF CHLORTHALIDONE AND PROCESS FOR PREPARING THEM	⤷ Sign Up
Slovenia	8410458	Process for preparing a water soluble, pharmaceutically acceptable dispersion of chlortalidone in solid state	⤷ Sign Up
South Korea	880001755		⤷ Sign Up
South Korea	840007874		⤷ Sign Up
Japan	S59176212	AQUEOUS SOLUTION DISPERSION OF CHLOROSALIDONE	⤷ Sign Up
Finland	841019		⤷ Sign Up
Canada	1212329	DISPERSIONS DE CHLORTHALIDONE (CHLORTHALIDONE DISPERSIONS)	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for THALITONE

Recent Clinical Trials for THALITONE

Pharmacology for THALITONE

Make Better Decisions: Try a trial or see plans & pricing